TEMPORAL CHANGES IN DIASTOLIC FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING SEQUENTIAL THERAPY WITH ANTHRACYCLINE AND TRASTUZUMAB

Temporal changes in diastolic function (DF) during cancer therapy have not been described in women with HER2+ breast cancer (BC). We sought quantify changes in DF during BC therapy. Fifty women (age 50.5±9.8 years) with HER2+ve BC treated with sequential anthracycline and trastuzumab were